-
[show abstract]
[hide abstract]
ABSTRACT: In this study, with the aim of designing an ideal anticancer drug carrier, we synthesized novel amphiphilic graft copolymers, P(Glu-alt-PEG)-graft-PCLA, based on poly(ethylene glycol) (PEG) segments and glutamic acid (Glu) units as the hydrophilic main chain, and poly(ɛ-caprolactone-co-lactide) (PCLA) as hydrophobic branches. The chemical structure of the copolymers was characterized by (1)H MNR and FT-IR. The self-assembly of the copolymers to form micelles was studied by TEM, DLS and fluorescence spectroscopy. In vitro doxorubicin controlled release studies demonstrated that these graft copolymer micelles had high drug loading capacity and good controlled released properties, demonstrating their potential as a novel anticancer drug carrier. The drug loaded graft copolymer micelles exhibited efficient inhibition of HeLa cells in in vitro studies.
Colloids and surfaces. B, Biointerfaces 10/2010; 85(1):86-91. · 2.60 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Climate change is now thought to be unequivocal, while its potential effects on global and public health cannot be ignored. However, the complexities of the causal webs, the dynamics of the interactions and unpredictability mean that climate change presents new challenges to epidemiology and magnifies existing methodological problems. This article reviews a number of such challenges, including topics such as exposure assessment, bias, confounding, causal complexities and uncertainties, with examples and recommendations provided where appropriate. Hence, epidemiology must continue to adapt by developing new approaches and the integration of other disciplines such as geography and climatology, with an emphasis on informing policy-making and disseminating knowledge beyond the field.
International Journal of Public Health 11/2009; 55(2):85-96. · 2.54 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: In this study, a KRGDKK (Lys-Arg-Gly-Asp-Lys-Lys) peptide with a RGD sequence is utilized as a functional group to synthesize a novel thermo-sensitive hydrogel. The KRGDKK peptide prepared by a solid phase synthesis approach is coupled to the ends of a poly[(epsilon-caprolactone)-co-lactide]-poly(ethylene glycol)-poly[(epsilon-caprolactone)-co-lactide] (PCLA-PEG-PCLA) triblock copolymer to obtain peptide-PCLA-PEG-PCLA-peptide. The self-assembly behavior of both PCLA-PEG-PCLA and peptide-PCLA-PEG-PCLA-peptide copolymers in aqueous solution is investigated, and hydrogels prepared from PCLA-PEG-PCLA and peptide-PCLA-PEG-PCLA-peptide are also prepared. An in vitro cell viability study demonstrated that the peptide-PCLA-PEG-PCLA-peptide hydrogels do not exhibit an apparent cytotoxicity, which suggests that the hydrogels have promising potential as injectable drug-delivery systems. Furthermore, compared with the PCLA-PEG-PCLA hydrogels, the peptide-PCLA-PEG-PCLA-peptide hydrogels display improved mechanical properties because of hydrogen bonding between the amino groups of KRGDKK. An in vitro drug release study showed that the peptide-PCLA-PEG-PCLA-peptide hydrogels exhibit outstanding controlled release properties and the release of the drug could be sustained for more than a month without initial burst.
Macromolecular Bioscience 11/2009; 9(12):1219-26. · 3.89 Impact Factor
